Foscarnet Treatment of Serious CMV Retinitis Infection in Patients With Acquired Immunodeficiency Syndrome

NCT00000726 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

53

Enrollment

NIH

Sponsor class

Conditions

Cytomegalovirus Retinitis
HIV Infections

Interventions

DRUG: Foscarnet sodium

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)